纽约 - 市值1.68亿美元的生物技术公司Liminatus Pharma, Inc. (NASDAQ: LIMN )在过去一周股价上涨超过18%，该公司周四发布的新闻稿显示，已与Digital Offering LLC签订合作协议，由后者担任其潜在战略融资的独家配售代理。

HELSINKI, July 30 (Xinhua) -- China has taken the lead in global green energy development, and Europe stands to benefit from closer and deeper cooperation with the country amid rising demand for clean ...

Investing.com -- Liminatus Pharma Inc (NASDAQ: LIMN )股价跳涨26.5%，此前这家临床前阶段的生物制药公司宣布已聘请Digital Offering LLC作为其潜在战略性融资的独家配售代理。